troglitazone has been researched along with Fistula in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, H | 1 |
Sato, Y | 1 |
Kanai, S | 1 |
Ichikawa, M | 1 |
Funakoshi, A | 1 |
Miyasaka, K | 1 |
1 other study available for troglitazone and Fistula
Article | Year |
---|---|
Increased lymphatic lipid transport in genetically diabetic obese rats.
Topics: Animals; Bile Acids and Salts; Body Weight; Carrier Proteins; Chromans; Diabetes Mellitus; Diabetes | 2002 |